Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
Liu
Na
N
Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, Peoples Republic of China.
Bi
Feng
F
Pan
Yanglin
Y
Sun
Lijun
L
Xue
Yan
Y
Shi
Yongquan
Y
Yao
Xuebiao
X
Zheng
Yi
Y
Fan
Daiming
D
D000362:Agar / Q000737:chemistry; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D015153:Blotting, Western; D002453:Cell Cycle; D002454:Cell Differentiation; D002461:Cell Line, Transformed; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D004247:DNA / Q000378:metabolism; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology; D004847:Epithelial Cells / Q000378:metabolism; D005434:Flow Cytometry; D005472:Fluorouracil / Q000494:pharmacology; D005799:Genes, Dominant; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D009154:Mutation; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009841:Oligonucleotides / Q000737:chemistry; D010641:Phenotype; D034741:RNA, Small Interfering / Q000378:metabolism; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000473:pathology*; D013778:Tetrazolium Salts / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D013997:Time Factors; D014162:Transfection; D014945:Wound Healing; D020742:rhoA GTP-Binding Protein / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009841:Oligonucleotides; D034741:RNA, Small Interfering; D013778:Tetrazolium Salts; D013844:Thiazoles; D004317:Doxorubicin; D000362:Agar; D004247:DNA; D020742:rhoA GTP-Binding Protein; C022616:thiazolyl blue; D005472:Fluorouracil